Literature DB >> 6322741

Memory modulation by post-training intraperitoneal, but not intracerebroventricular, administration of ACTH or epinephrine.

M A de Almeida, F P Kapczinski, I Izquierdo.   

Abstract

Post-training introparitoneal (ip) administration of ACTH1-24 (25 ng/rat) or epinephrine HCl (625 ng/rat) facilitated retention of a step-down inhibitory avoidance task acquired using a small start platform (5-cm high, 25 X 7 cm) and a low intensity training footshock (0.3 mA, 60 Hz), and caused retrograde amnesia for a similar task acquired using a large platform (5-cm high, 25 X 25 cm) and a high intensity training footshock (0.8 mA, 60 Hz). The post-training intracerebroventricular (icv) administration of 5, 25, or 125 ng/rat of ACTH or of 5, 25, 125, 625, or 1250 ng/rat of epinephrine had no effect on retention of either task. These findings suggest that memory modulation by ACTH and epinephrine is mediated by reflexes initiated at peripheral receptors that affect brain activity during the post-training period.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6322741     DOI: 10.1016/s0163-1047(83)90961-5

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  4 in total

Review 1.  An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers.

Authors:  G L Wenk
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Regulation of memory - from the adrenal medulla to liver to astrocytes to neurons.

Authors:  Paul E Gold
Journal:  Brain Res Bull       Date:  2014-01-07       Impact factor: 4.077

3.  Impairment of active avoidance by the noradrenergic neurotoxin, DSP4: attenuation by post-training epinephrine.

Authors:  M C Bennett; S Kaleta-Michaels; M Arnold; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Naloxone prevents the facilitatory effect upon retention induced by adrenaline administration in rats.

Authors:  S del Cerro; J Borrell
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.